Video

Kaposi's Sarcoma Makes Unwelcome Return


 

Kaposi's sarcoma is making a comeback in aging HIV patients, even among those with well-controlled disease. Dr. Kieron S. Leslie, an associate clinical professor of dermatology at the University of California, San Francisco, discusses the cancer's return and its implications for patients with HIV.

Recommended Reading

Ridaforolimus Fails to Sway FDA Panel in Sarcoma Bid
MDedge Hematology and Oncology
FDA Panel Backs Pazopanib for Sarcoma
MDedge Hematology and Oncology
ASCO: Stop Underdosing Obese Cancer Patients
MDedge Hematology and Oncology
Cixutumumab With Temsirolimus Slows Ewing's Sarcoma
MDedge Hematology and Oncology
FDA Approves Pazopanib for Advanced Soft-Tissue Sarcomas
MDedge Hematology and Oncology
Laparoscopy Tops Open Resection for Most Gastric Tumors
MDedge Hematology and Oncology
Regorafenib Delays Progression of Refractory Metastatic GIST
MDedge Hematology and Oncology
FDA Announces Limited Leucovorin Recall
MDedge Hematology and Oncology
FDA Warns of QT Prolongation with Ondansetron Dose
MDedge Hematology and Oncology
Washington Post Blasts Proliferation of ESAs for Anemia
MDedge Hematology and Oncology